Prevail Therapeutics

Prevail Therapeutics

Prevail Therapeutics

Prevail Therapeutics, Inc is an emerging biotech company based in New York City that is developing therapeutics for brain disorders such as Parkinson's disease.
Type
B2c
Founded
2017
Raised
$75M
Follow us
Alexa global traffic share
08 Mar 2018
$75,000,000
Venture capital (Series A)

Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech

Xconomy
+1